Please wait while we open this resource.
K
Clinical reviews
THE NEW ERA OF ADD-ON ASTHMA TREATMENTS: WHERE DO WE STAND?
William J. Calhoun and Geoffrey L. Chupp
PDF13 pages3.5 MB
Severe asthma, affecting a small percentage of patients, leads to significant healthcare resource use. The Global Initiative for Asthma (GINA) provides guidelines for managing asthma, recommending inhaled corticosteroids and long-acting beta-agonists, with biologics as potential add-ons. This review evaluates recent advancements in asthma treatment, including the role of biologics and small-molecule drugs, and proposes an algorithm for managing severe asthma based on GINA recommendations. The future of asthma treatment may increasingly rely on personalized approaches informed by biomarkers.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
CHALLENGES OF SARCOIDOSIS AND ITS MANAGEMENT
Same clinical topic · Pulmonology
PLEURAL EFFUSION IN CRITICALLY ILL PATIENTS AND INTENSIVE CARE SETTING
Same clinical topic · Pulmonology
OBESITY AND ACUTE PULMONARY EMBOLISM
Same clinical topic · Pulmonology
Management of Life-Threatening Asthma
Same clinical topic · Pulmonology
Management of Life-Threatening Asthma
Same clinical topic · Pulmonology
INTERSTITIAL LUNG DISEASES
Same clinical topic · Pulmonology
DIAGNOSTIC ACCURACY OF CHEST X-RAY SCREENING FOR SILICOSIS: A SYSTEMATIC REVIEW, META-ANALYSIS AND MODELLING STUDY
Same clinical topic · Pulmonology
Definitions of non-response and response to biological therapy for severe asthma: a systematic review
Same clinical topic · Pulmonology
SYMPTOMATOLOGY AND PHYSICAL EXAMINATION OF RESPIRATORY DISEASE
Same clinical topic · Pulmonology